510(k) Report

510(k) · Cleared

Cleared

ALBP

K981457510(k) TraditionalCleared May 27, 199834-day reviewClass II21 CFR 862.1035

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Abbott Mfg., Inc. · CJW Bromcresol Purple Dye-Binding, Albumin

Cleared on May 27, 1998 as substantially equivalent to K844426 (Boehringer Mannheim Corp., 1985) after a 34-day review. Its family tree reaches back 1 generation to 1985.

Decided
May 27, 1998
Review
34 days
Class
Class II
Product code
CJW
Recalls
None
Predicates
1

Its longest line of descent runs back 1 generation to K844426 (1985). No later device cites it as a predicate yet.

K844426 · Albumin BCP · Boehringer Mannheim Corp. · 1985 · recalled1985199019952000
K844426 · Albumin BCP · Boehringer Mannheim Corp. · 1985 · recalled0
  1. Root · 1 generation backK844426 Albumin BCPBoehringer Mannheim Corp. · 1985 · Recalled
  2. This deviceK981457 ALBPAbbott Mfg., Inc. · 1998
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−1K844426Albumin BCPBoehringer Mannheim Corp.19851
0 (this device)K981457ALBPAbbott Mfg., Inc.1998—
FIG. 1 — Lineage of K981457, 1985–1998Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in CJW? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new CJW device

  1. #1 K203530 Albumin BCP2score 3.3 · 2 generations · no Class I recall
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K844426Albumin BCP
Summary page 1
…l to the albumin concentration in the sample. Substantial Equivalence: The Albumin BCP assay is substantially equivalent to the Boehringer Mannheim® Albumin BCP Assay (K844426) on the Hitachi® 717 Analyzer. Both assays yield similar Performance Characteristics. Albumin BCP 510(k) Section II April 22, 1…
Boehringer Mannheim Corp.19851

Also cleared against K844426: 1 other device →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Its one ancestor has a recall.
  • 1 other device also cites its predicate K844426.

How does its category compare?

All CJW devices

CJW Bromcresol Purple Dye-Binding, Albumin: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · CJW

1in 2022

2013: 12019: 12022: 1
2007high 1 (2013) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · CJW

Too few CJW 510(k)s in any year since 2007 to give a median.

Recalls per year · CJW

No recall names CJW since 2007.

Adverse event reports per year · CJW

1in 2025

2007: 12009: 12010: 12011: 12017: 12019: 32021: 52023: 22024: 12025: 1
2007high 5 (2021) · low 0 (2008)2025

MAUDE reports naming product code CJW, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—01
20080—00
20090—01
20100—01
20110—01
20120—00
20131—00
20140—00
20150—00
20160—00
20170—01
20180—00
20191—03
20200—00
20210—05
20221—00
20230—02
20240—01
20250—01
20260—0—

What is it indicated for?

The Albumin BCP assay is used for the quantitation of albumin in human serum.

Albumin BCP measurements are used in the diagnosis and treatment of kidney disease and liver disease.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K981457: ALBP.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K981457

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026